Search results
Results from the WOW.Com Content Network
Hyperhidrosis is the medical term for excessive sweating in the underarms, face, scalp, palms and feet, according to Johns Hopkins Medicine, which also notes that people experiencing it often ...
In March, the CDC updated the Respiratory Virus Guidance as COVID-19 cases have decreased over time. “It is still an important health threat, but it is no longer the emergency that it once was ...
Pneumonia, the flu, Covid-19, tuberculosis, mononucleosis, and HIV are infections that might increase sweating. Contact your doctor if you also have a high fever, difficulty breathing, or a high ...
Longer-term effects of COVID-19 have become a prevalent aspect of the disease itself. These symptoms can be referred to as many different names including post-COVID-19 syndrome, long COVID, and long haulers syndrome. An overall definition of post-COVID conditions (PCC) can be described as a range of symptoms that can last for weeks or months. [83]
Hyperhidrosis is a medical condition in which a person exhibits excessive sweating, [1] [2] more than is required for the regulation of body temperature. [3] Although it is primarily a physical burden, hyperhidrosis can deteriorate the quality of life of the people who are affected from a psychological, emotional, and social perspective. [4]
The onset of symptoms was sudden, with death often occurring within hours. Sweating sickness epidemics were unique compared with other disease outbreaks of the time: whereas other epidemics were typically urban and long-lasting, cases of sweating sickness spiked and receded very quickly, and heavily affected rural populations. [2]
Health care professionals stress the importance of being up-to-date with shots for COVID-19, flu and RSV − respiratory syncytial virus. All three infections are likely to be on the upswing as ...
Focal hyperhidrosis, also known as primary hyperhidrosis, is a disease characterized by an excessive sweating localized in certain body regions (particularly palms, feet and underarms). Studies suggest that this condition, affecting between 1% and 3% of the US population, seems to have a genetic predisposition in about two thirds of those affected.